• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

EnteroMedics Inc

+ Add to Watchlist

BY8N:GR

1.164 EUR 0.044 3.93%

As of 04:55:04 ET on 04/17/2014.

Snapshot for EnteroMedics Inc (BY8N)

Open: 1.134 Day's Range: 1.134 - 1.164 Volume: 0
Previous Close: 1.120 52wk Range: 0.598 - 2.300 1-Yr Rtn: +93.68%

Stock Chart for BY8N

No chart data available.
  • BY8N:GR 1.164
  • 1D
  • 1M
  • 1Y
1.120
Interactive BY8N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BY8N

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4000
Est. PEG Ratio -
Market Cap (M EUR) 77.49
Shares Outstanding (M) 66.57
30 Day Average Volume 4,480
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BY8N

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BY8N

EnteroMedics Inc. is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders.

Mark B KnudsonChairman/President/CEOGregory S Lea "Greg"Senior VP/CFO/COO/Secretary
Adrianus Donders "Jos"Senior VP:ResearchKatherine S TwedenVP:Clinical & Regulatory
More Company Profile & Key Executives for BY8N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil